Fenfluramine 2.2 mg/mL Oral Solution
RxNorm 2381138
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2381138 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: fenfluramine 2.2 mg/mL Oral Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Fenfluramine 2.2 mg/ML Oral Solution
(Atom ID: 12412629)
SYPrescribable
Synonym (SY):
Fenfluramine 2.2 mg/ML (as fenfluramine HCl 2.5 mg/ML) Oral Solution
(Atom ID: 12412639)
PSNPrescribable
Prescribable Name (PSN):
Fenfluramine 2.2 mg/mL Oral Solution
(Atom ID: 12759638)
PTPrescribable
Designated preferred name (PT):
Fenfluramine 2.2 mg/mL oral solution
(Atom ID: 12536790)
FNPrescribable
Full form of descriptor (FN):
Product containing precisely fenfluramine 2.2 mg/1 mL conventional release oral solution (clinical drug)
(Atom ID: 12537628)
Patient Education
Fenfluramine
Fenfluramine is used to control seizures in children from 2 years of age and older with Dravet syndrome (a disorder that begins in early childhood and causes seizures and later may lead to developmental delays and changes in eating, balance, and walking). Fenfluramine is in a class of medications called anticonvulsants. It is not known exactly how fenfluramine works, but it increases the amount of natural substances in the brain that may reduce seizure activity.
[Learn More]
* Please review the disclaimer below.